Microvascular adaptive changes in experimental endogenous brain gliomas

Histology and Histopathology

Volumn 24, Issue 6, 2009, Pages 693-706

  Bulnes, Susana ^a   Bilbao, Juan ^a   Lafuente, José Vicente ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Angiogenesis; Blood brain barrier (BBB); Ethylnitrosourea (ENU); Gliomas; Microvascular network

Indexed keywords

RATTUS;

CARCINOGEN; ETHYLNITROSOUREA;

ANIMAL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TUMOR; CAPILLARY PERMEABILITY; CHEMICALLY INDUCED DISORDER; GLIOMA; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CAPILLARY PERMEABILITY; CARCINOGENS; ETHYLNITROSOUREA; GLIOMA; IMMUNOHISTOCHEMISTRY; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, SPRAGUE-DAWLEY;

EID: 67650228174     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Anderson S.A., Glod J., Arbab A.S., Noel M., Ashari P., Fine H.A. and Frank J.A. (2005). Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 105, 420-425.
2. Argandona E.G. and Lafuente J.V. (1996). Effects of dark-rearing on the vascularization of the developmental rat visual cortex. Brain. Res. 732, 43-51.
3. Argandona E.G. and Lafuente J.V. (2000). Influence of visual experience deprivation on the postnatal development of the microvascular bed in layer IV of the rat visual cortex. Brain Res. 855, 137-142.
4. Argandona E.G., Bengoetxea H. and Lafuente J.V. (2005). Lack of experience-mediated differences in the immunohistochemical expression of blood-brain barrier markers (EBA and GluT-1) during the postnatal development of the rat visual cortex. Brain Res. Dev. Brain Res. 156, 158-166.
5. Baluk P., Hashizume H. and McDonald D.M. (2005). Cellular abnormalities of blood vessels as targets in cancer. Curr. Opin. Genet. Dev. 15, 102-111.
6. Ballabh P., Braun A. and Nedergaard M. (2004). The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 16, 1-13.
7. Barbosa M., Rios O., Velasquez M., Villalobos J. and Ehrmanns J. (2001). Acetylcholinesterase and butyrylcholinesterase histochemical activities and tumor cell growth in several brain tumors. Surg. Neurol. 55, 106-112.
8. Bengoetxea H., Argandona E.G. and Lafuente J.V. (2008). Effects of visual experience on vascular endothelial growth factor expression during the postnatal development of the rat visual cortex. Cereb. Cortex. 18, 1630-1639
9. Bergers G. and Benjamin L.E. (2003). Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer. 3, 401-410
10. Bian X.W., Jiang X.F., Chen J.H., Bai J.S., Dai C., Wang Q.L., Lu J.Y., Zhao W., Xin R., Liu M.Y., Shi J.Q. and Wang J.M. (2006). Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas. Int. Immunopharmacol. 6, 90-99.
11. Bigner D.D., McLendon R.E., and Bruner J.M. (1998). Russell & Rubinstenin ́s. Pathology of tumors of the nervous system. 6th ed. Arnold. London
12. Blouw B., Song H., Tihan T., Bosze J., Ferrara N., Gerber H.P., Johnson R.S. and Bergers G. (2003). The hypoxic response of tumors is dependent on their microenvironment. Cancer. Cell 4, 133-146.
13. Brasch R. and Turetschek K. (2000). MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report. Eur. J. Radiol. 34, 148-155.
14. Brasch R.C., Gossmann A., Helbich T.H., Kuriyama N., Roberts T.P., Shames D.M., van Bruggen N., Wendland M.F. and Israel M.A. (2002). Can a small-molecular gadolinium contrast agent be applied successfully with dynamic MRI to quantitatively define brain tumor microvascular responses to angiogenesis inhibition?. Acad. Radiol. 9 Suppl. 2, 326-327.
15. Brat D.J. and Van Meir E.G. (2001). Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research. Am. J. Pathol. 158, 789-796.
16. Brat D.J., Castellano-Sanchez A.A., Hunter S.B., Pecot M., Cohen C., Hammond E.H., Devi S.N., Kaur B. and Van Meir E.G. (2004). Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res. 64, 920-927.
17. Bulnes S. and Lafuente J.V. (2007). VEGF immunopositivity related to malignancy degree, proliferative activity and angiogenesis in ENUinduced gliomas. J. Mol. Neurosci. 33, 163-172.
18. Bulnes-Sesma S., Ullibarri-Ortiz de Z.N. and Lafuente-Sanchez J.V. (2006). Tumour induction by ethylnitrosourea in the central nervous system. Rev. Neurol. 43, 733-738.
19. Carmeliet P. and Jain R.K. (2000). Angiogenesis in cancer and other diseases. Nature 407, 249-257
20. Cha S., Johnson G., Wadghiri Y.Z., Jin O., Babb J., Zagzag D. and Turnbull D.H. (2003). Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn. Reson. Med. 49, 848-855.
21. Claes A., Gambarota G., Hamans B., van T.O., Wesseling P., Maass C., Heerschap A. and Leenders W. (2008). Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment. Int. J. Cancer. Int. J. Cancer 122, 1981-1986.
22. Cornford E.M. and Hyman S. (2005). Localization of brain endothelial luminal and abluminal transporters with immunogold electron microscopy. NeuroRx. 2, 27-43.
23. Dobrogowska D.H. and Vorbrodt A.W. (1999). Quantitative immunocytochemical study of blood-brain barrier glucose transporter (GLUT-1) in four regions of mouse brain. J. Histochem. Cytochem. 47, 1021-1030.
24. Dvorak H.F. (2006). Discovery of vascular permeability factor (VPF). Exp. Cell Res. 312, 522-526.
25. Engelhard H.H., Stelea A. and Cochran E.J. (2002). Oligodendroglioma: pathology and molecular biology. Surg. Neurol. 58, 111-117.
26. Fan X., Salford L.G. and Widegren B. (2006). Glioma stem cells: Evidence and limitation. Semin. Cancer Biol. 17, 214-218.
27. Ferrara N., Gerber H.P. and LeCouter J. (2003). The biology of VEGF and its receptors. Nat. Med. 9, 669-676.
28. Folkman J. (2000). Tumour angiogenesis, in cancer medicine. In: Cancer medicine Hamilton. Hollan J.F., Frei E., Bast R.C., Kufe D.W., Pollock R.E. and Weichselbaum R.R. (eds). B.C. Decker Inc. Ontario, Canada. pp 132-152.
29. Fonta C. and Imbert M. (2002). Vascularization in the primate visual cortex during development. Cereb. Cortex. 12, 199-211.
30. Harhaj N.S. and Antonetti D.A. (2004). Regulation of tight junctions and loss of barrier function in pathophysiology. Int. J. Biochem. Cell Biol. 36, 1206-1237.
31. Hashizume H., Baluk P., Morikawa S., McLean J.W., Thurston G., Roberge S., Jain R.K. and McDonald D.M. (2000). Openings between defective endothelial cells explain tumor vessel leakiness. Am. J. Pathol. 156, 1363-1380.
32. Helmlinger G., Endo M., Ferrara N., Hlatky L. and Jain R.K. (2000). Formation of endothelial cell networks. Nature 405, 139-141.
33. Holash J., Maisonpierre P.C., Compton D., Boland P., Alexander C.R., Zagzag D., Yancopoulos G.D. and Wiegand S.J. (1999). Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284, 1994-1998.
34. Huber J.D., Egleton R.D. and Davis T.P. (2001). Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 24, 719-725.
35. Jensen R.L. (2006). Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measures. Neurosurg. Focus. 20, E24.
36. Jin K.L., Mao X.O., Nagayama T., Goldsmith P.C. and Greenberg D.A. (2000). Induction of vascular endothelial growth factor and hypoxiainducible factor-1alpha by global ischemia in rat brain. Neuroscience 99, 577-585.
37. Kish P.E., Blaivas M., Strawderman M., Muraszko K.M., Ross D.A., Ross B.D. and McMahon G. (2001). Magnetic resonance imaging of ethyl-nitrosourea-induced rat gliomas: a model for experimental therapeutics of low-grade gliomas. J. Neurooncol. 53, 243-257.
38. Kleihues P., Burger P.C., Collins V.P., Newcomb E.W., Ohgaki H. and Cavenee W.K. (2000). Glioblastoma. In: Pathology and genetics of tumours of the nervous system. Kleihues P. and Cavenee W.K. (eds). International Agency for Research on Cancer (IARC). Lyon. pp 29-39.
39. Korkolopoulou P., Patsouris E., Kavantzas N., Konstantinidou A.E., Christodoulou P., Thomas-Tsagli E., Pananikolaou A., Eftychiadis C., Pavlopoulos P.M., Angelidakis D., Rologis D. and Davaris P. (2002). Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms. Neuropathol. Appl. Neurobiol. 28, 57-66.
40. Krum J.M., Mani N. and Rosenstein J.M. (2002). Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Neuroscience 110, 589-604
41. Lafuente J.V. (2004). Involvement and consequences of Blood Brain Barrier permeability after minimal injury in rat cerebral cortex. In: Blood-spinal cord and brain barriers in health and disease. Sharma H.S. (eds). Elsevier Academic Press. San Diego, California. pp 533-545.
42. Lafuente J.V., Cervos-Navarro J. and Gutierrez Argandona E. (1994). Evaluation of BBB damage in an UV irradiation model by endogenous protein tracers. Acta Neurochir. Suppl. (Wien). 60, 139-141.
43. Lafuente J.V., Adán B., Alkiza K., Garibi J.M., Rossi M. and Cruz- Sánchez F.F. (1999). Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-beta (PDGFR-beta) in human gliomas. J. Mol. Neurosci. 13, 177-185.
44. Lafuente J.V., Alkiza K., Garibi J.M., Alvarez A., Bilbao J., Figols J. and Cruz-Sanchez F.F. (2000). Biologic parameters that correlate with the prognosis of human gliomas. Neuropathology 20, 176-183.
45. Lafuente J.V., Argandona E.G. and Mitre B. (2006). VEGFR-2 expression in brain injury: its distribution related to brain-blood barrier markers. J. Neural. Transm. 113, 487-496.
46. Lin B. and Ginsberg M.D. (2000). Quantitative assessment of the normal cerebral microvasculature by endothelial barrier antigen (EBA) immunohistochemistry: application to focal cerebral ischemia. Brain Res. 865, 237-244.
47. Machein M.R., Knedla A., Knoth R., Wagner S., Neuschl E. and Plate K.H. (2004). Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model. Am. J. Pathol. 165, 1557-1570.
48. Mack A. and Robitzki A. (2000). The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense- 5'butyrylcholinesterase-DNA study. Prog. Neurobiol. 60, 607-628.
49. Marti H.J., Bernaudin M., Bellail A., Schoch H., Euler M., Petit E. and Risau W. (2000). Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am. J. Pathol. 156, 965-976.
50. Mazzetti S., Librizzi L., Frigerio S., de Curtis M. and Vitellaro-Zuccarello L. (2004). Molecular anatomy of the cerebral microvessels in the isolated guinea-pig brain. Brain Res. 999, 81-90.
51. Mennel H.D., Kosse N., Heverhagen J.T. and Alfke H. (2004). Primary and transplanted ENU induced rat tumors in neurooncology. Exp. Toxicol. Pathol. 56, 25-35.
52. Papadopoulos M.C., Saadoun S., Binder D.K., Manley G.T., Krishna S. and Verkman A.S. (2004). Molecular mechanisms of brain tumor edema. Neuroscience 129, 1011-1020.
53. Perry J.R. (2001). Oligodendrogliomas: clinical and genetic correlations. Curr. Opin. Neurol. 14, 705-710.
54. Quarles C.C. and Schmainda K.M. (2007). Assessment of the morphological and functional effects of the anti-angiogenic agent SU11657 on 9L gliosarcoma vasculature using dynamic susceptibility contrast MRI. Magn. Reson. Med. 57, 680-687.
55. Risau W. (1997). Mechanisms of angiogenesis. Nature 386, 671-674.
56. Roberts H.C., Roberts T.P., Brasch R.C. and Dillon W.P. (2000a). Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. Am. J. Neuroradiol. 21, 891-899.
57. Roberts T.P., Chuang N. and Roberts H.C. (2000b). Neuroimaging: do we really need new contrast agents for MRI? Eur. J. Radiol. 34, 166-178.
58. Rosenstein J.M., Mani N., Silverman W.F. and Krum J.M. (1998). Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95, 7086-7091.
59. Ruoslahti E. (2002). Specialization of tumour vasculature. Nat. Rev. Cancer 2, 83-90.
60. Semenza G.L. (2003). Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721-732.
61. Slikker W., Mei N. and Chen T. (2004). N-ethyl-N-nitrosourea (ENU) increased brain mutations in prenatal and neonatal mice but not in the adults. Toxicol. Sci. 81, 112-120.
62. Sternberger N.H., Sternberger L.A., Kies M.W. and Shear C.R. (1989). Cell surface endothelial proteins altered in experimental allergic encephalomyelitis. J. Neuroimmunol. 21, 241-248.
63. Vajkoczy P. and Menger M.D. (2004). Vascular microenvironment in gliomas. Cancer Treat. Res. 117, 249-262.
64. Vajkoczy P., Farhadi M., Gaumann A., Heidenreich R., Erber R., Wunder A., Tonn J.C., Menger M.D. and Breier G. (2002). Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J. Clin. Invest. 109, 777-785.
65. Wesseling P., van der Laak J.A., Link M., Teepen H.L. and Ruiter D.J. (1998). Quantitative analysis of microvascular changes in diffuse astrocytic neoplasms with increasing grade of malignancy. Hum. Pathol. 29, 352-358.
66. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J. and Holash J. (2000). Vascular-specific growth factors and blood vessel formation. Nature 407, 242-248.
67. Yao H., Sugimori H., Fukuda K., Takada J., Ooboshi H., Kitazono T., Ibayashi S. and Iida M. (2003). Photothrombotic middle cerebral artery occlusion and reperfusion laser system in spontaneously hypertensive rats. Stroke 34, 2716-2721.
68. Yeh W.L., Lin C.J. and Fu W.M. (2008). Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia. Mol. Pharmacol. 73, 170-177.
69. Zhu C., Ghabriel M.N., Blumbergs P.C., Reilly P.L., Manavis J., Youssef J., Hatami S. and Finnie J.W. (2001). Clostridium perfringens prototoxin-induced alteration of endothelial barrier antigen (EBA) immunoreactivity at the blood-brain barrier (BBB). Exp. Neurol. 169, 72-82.
70. Zook B.C. and Simmens S.J. (2005). Neurogenic tumors in rats induced by ethylnitrosourea. Exp. Toxicol. Pathol. 57, 7-14.